ArticleBritish journal of cancer2025

PROCC: a predictive score to identify KRAS wild type metastatic colorectal cancer patients who are likely to obtain survival benefit from panitumumab treatment.

Carlos María Galmarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.